RSS

Donald Trump

A brief round up of some of the latest developments in the industry, including a review into medical marijuana and a potential win for Trump in drug pricing… more

Opinion

May and Trump

AL hutluht / Shutterstock.com

A black-tie dinner has been arranged for UK business leaders — including big pharma CEOs — and the US president, Donald Trump, to be hosted by the prime minister, Theresa May, according to an article published in the Financial Times (FT). more

News

Just after Alex Azar has been sworn in as the new Secretary of Health and Human Services under President Trump, many have been asking the question if he will be able to make good on his claim to prioritise the reduction of prescription drug costs more

News

Trump

GrAl / Shutterstock.com

US president, Donald Trump, has nominated Alex Azar — a former pharmaceutical executive — as his next health secretary. more

News

After the Charlottesville protests over the weekend, during which one woman was killed and several others injured, three business leaders have quit Trump’s council as a result of him not taking a harder stance on the issue. more

News

After President Trump’s announcement of budget cuts to US governmental scientific agencies last week, the ISCT has stated that ramifications to science, clinical care and patients in the US and internationally will be severe and harmful. more

News

Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities, say the experts. more

News

A snap poll conducted by Endpoints News has gauged the biotech industry’s reception to the travel ban imposed by president Donald Trump. more

News

An executive order signed by president Donald Trump to freeze all federal government hiring could negatively affect the US Food and Drug Administration’s (FDA) progress towards approving new drugs, medical devices and generic drugs. more

News

trump.jpg

GrAl / Shutterstock.com

Donald Trump is now President-elect of the United States of America. The news is a surprise to many across the world, but the pharma industry has been predicting the implications of his election for some time. more

News

Trump.jpg

Image:a katz

Donald Trump has said that “$300 billion could be saved” by making Medicare, the US federal health insurance programme, negotiate drug prices with pharma companies more

Opinion